Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124068652 | 12406865 | 2 | F | 20160510 | 20160712 | 20160526 | 20160719 | EXP | CA-TAKEDA-2016MPI004467 | TAKEDA | 65.00 | YR | F | Y | 0.00000 | 20160719 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124068652 | 12406865 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | 1.3 MG/M2, UNK | Y | 21602 | 1.3 | MG/M**2 | INJECTION | ||||||
| 124068652 | 12406865 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 20 MG, 1/WEEK | Y | 0 | 20 | MG | /wk | ||||||
| 124068652 | 12406865 | 3 | SS | POMALIDOMIDE | POMALIDOMIDE | 1 | Unknown | 4 MG, UNK | Y | 0 | 4 | MG | |||||||
| 124068652 | 12406865 | 4 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 81 MG, UNK | 0 | 81 | MG | ||||||||
| 124068652 | 12406865 | 5 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | Unknown | 400 MG, BID | 0 | 400 | MG | BID | |||||||
| 124068652 | 12406865 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 124068652 | 12406865 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
| 124068652 | 12406865 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 300 MG, BID | 0 | 300 | MG | CAPSULE | BID | ||||||
| 124068652 | 12406865 | 9 | C | HYDROMORPHONE HYDROCHLORIDE. | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 124068652 | 12406865 | 10 | C | HYDROMORPHONE HYDROCHLORIDE. | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 12 MG, BID | 0 | 12 | MG | BID | |||||||
| 124068652 | 12406865 | 11 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 124068652 | 12406865 | 12 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124068652 | 12406865 | 1 | Plasma cell myeloma |
| 124068652 | 12406865 | 2 | Plasma cell myeloma |
| 124068652 | 12406865 | 3 | Plasma cell myeloma |
| 124068652 | 12406865 | 12 | Bone pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124068652 | 12406865 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124068652 | 12406865 | Abdominal pain | |
| 124068652 | 12406865 | Avulsion fracture | |
| 124068652 | 12406865 | Dizziness | |
| 124068652 | 12406865 | Dysuria | |
| 124068652 | 12406865 | Nausea | |
| 124068652 | 12406865 | Plasma cell myeloma | |
| 124068652 | 12406865 | Pneumonia | |
| 124068652 | 12406865 | Skin mass | |
| 124068652 | 12406865 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124068652 | 12406865 | 1 | 20160415 | 0 |